Dapeng Zhou

Title: Dapeng Zhou: Innovator in Immunotherapy

Introduction

Dapeng Zhou is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative research and patented technologies. His work focuses on enhancing the immune response against cancer and viral infections.

Latest Patents

Dapeng Zhou holds a patent for "Nanoparticle formulated glycolipid antigens for immunotherapy." This composition is designed to stimulate NKT cells to produce anti-cancer and anti-viral cytokines without causing anergy of NKT cells. The invention includes a glycolipid antigen and a nanoparticle conjugated with the glycolipid antigen. Notably, both the glycolipid antigen and the nanoparticle are non-antigenic in mice and humans. The patent outlines a method for preparing the composition, which involves loading the glycolipid antigen onto the nanoparticle, either by coating the surface or encapsulating it within. This innovative approach aims to enhance the efficacy of immunotherapy treatments.

Career Highlights

Throughout his career, Dapeng Zhou has worked with esteemed institutions such as the University of Texas System and The Scripps Research Institute. His research has contributed to advancements in the understanding of immune responses and therapeutic applications.

Collaborations

Dapeng Zhou has collaborated with notable colleagues, including Chun Li and Luc Teyton. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field of immunotherapy.

Conclusion

Dapeng Zhou's contributions to immunotherapy through his patented inventions highlight his role as a leading innovator in the field. His work continues to pave the way for new therapeutic strategies against cancer and viral diseases.